Basil Kaufmann

Pre- and postradical cystectomy tumor-informed ctDNA dynamics is a powerful predictor of oncological outcomes: those who convert from detectable to undetectable ctDNA fare worse than those staying undetectable @ReubenBenDavid1 @MehrazinMD @DrJohnSfakianos doi.org/10.1111/bju.16…

Online now: The use of 99mTc-tetrofosmin in the characterisation of indeterminate renal masses: a pilot study @cpavmd @michael_gorin @BasilKaufmann doi.org/10.1111/bju.16…

@CDFankhauser @KantonsspitalLU @intuitive @AgostinoMattei @wuernsch @IntuitiveSurg @RoboticsUrology Amazing. Congrats to your team!🥳

@KantonsspitalLU @intuitive So pleased we were selected as the first site to offer single port robotics in Europe! @AgostinoMattei @wuernsch Thank you for your guidance @IntuitiveSurg @RoboticsUrology

Dürfen wir vorstellen? Unser neuer OP-Roboter «Da Vinci SP». Der revolutionäre Roboter ermöglicht unseren hochkompetenten Chirurginnen und Chirurgen Operationen mit einem einzigen, minimalinvasiven Zugang. #Innovation #DaVinciSP @Intuitive Mehr dazu: luks.ch/newsroom/luks-…

@ReubenBenDavid1 Great work Reuben!👏

Thrilled on our lastest publication in European Urology Oncology! ctDNA may revolutionize the way we choose treatment modalities for patients with bladder cancer. Paving our way in adding the letter G-for genomic to TNM staging, adding another layer of clarity to our patients. authors.elsevier.com/a/1ioXj9Cfv--d… @DrJohnSfakianos @MehrazinMD @NDTillu @IcahnMountSinai @MountsinaiUro

@ReubenBenDavid1 @MehrazinMD @DrJohnSfakianos @MountsinaiUro @AshTewariMD Congrats Reuben!👏

My first time at #GU24. Such an incredible experience as a urologist! Thanks to my mentors @MehrazinMD and @DrJohnSfakianos for supporting and facilitating the work with ctDNA in kidney and testis cancer! Thanks to @MountsinaiUro @AshTewariMD for the continues support.

Online now: SAFE technique to improve Nerve-Sparing in Robotic-Assisted Radical Prostatectomy #ProstateCancer @PedrazaAdrianaM @BasilKaufmann @michael_gorin & colleagues doi.org/10.1111/bju.16…

Just published: Focal Therapy with High-Intensity Focused Ultrasound for #ProstateCancer: Three Year Outcomes from a Prospective Trial by @BasilKaufmann @michael_gorin @deberli and colleagues bjui-journals.onlinelibrary.wiley.com/doi/abs/10.111…

@CDFankhauser @BJUIjournal @PedrazaAdrianaM @michael_gorin Congrats to @PedrazaAdrianaM !!

@BJUIjournal @PedrazaAdrianaM @BasilKaufmann @michael_gorin congrats @BasilKaufmann and team!

@ReubenBenDavid1 @Ruben_De_Groote @alexmottrie @FarinhaUrologia @PuliattiStefano @orsiacademy @MountSinaiNYC @AshTewariMD Yes, amazing job done! Thank you!👌

@Ruben_De_Groote @alexmottrie @FarinhaUrologia @PuliattiStefano @orsiacademy @MountSinaiNYC @AshTewariMD Thank you for having the opportunity to train with you! 👏 Improving and standardizing the education of robotic surgeries.

Honoured to have been part of the first Proficiency Based Progression (PBP) Orsi-Mount Sinai course in New York City @FarinhaUrologia @PuliattiStefano @orsiacademy @MountSinaiNYC @alexmottrie @AshTewariMD

@CDFankhauser @UniLuzern @hirslanden @KantonsspitalLU Congrats Chrigi! Sehr verdient!!🥳🎊

@UniLuzern @hirslanden @KantonsspitalLU 🎉 Honored and grateful to be appointed as a Professor at the University of Luzern. Excited to take on the role of motivating young talents and supporting them in pursuing a surgeon-scientist career. Thank you, @UniLuzern @KantonsspitalLU, for this incredible opportunity! 📚👨‍🏫

Die Universität Luzern hat PD Dr. med. Christian Fankhauser, Prof. Dr. med. Philipp Szavay und PD Dr. med. Daniel Waldvogel zu Titularprofessoren für Medizinische Wissenschaften ernannt. unilu.ch/news/ernennung… @hirslanden @KantonsspitalLU

@AshTewariMD Wow, congrats to all of you!!🥳🎊

Genitourinary cancer neoadjuvant therapies: current and future approaches: Trends in Cancer. We made it on the cover. cell.com/trends/cancer/…

@IndiaHamburg Is this data published anywhere? I would need a source of reference.

Double treatment in the same setting during focal HIFU leads to significantly lower infield recurrence, in our cohort down to 4 %! Focal therapy has a bright future, with good results we can convince better!😉

Evaluation of #Proclarix in the diagnostic work-up of #ProstateCancer - Online and #OpenAccess now @CPMS1B @BasilKaufmann @UweBieri @UZH_en bjui-journals.onlinelibrary.wiley.com/doi/full/10.10…

@DrJohnSfakianos @MattGalsky @MountsinaiUro Amazing, congratulations!👏

A really great collaborative trial between GU med onc and Urologic oncology. Clearly showing bladder sparring can benefit a subset of patients. A lot more work to be done and excited to partner with @MattGalsky to continue help figure this out for our patients. @MountsinaiUro

Go check it out! Amazing team: @Jordan_M_Rich @GrauerRalph @BasilKaufmann @KruPandav @Sood11 @AshTewariMD @MMenonMD @HitenDPatel @michael_gorin

@CDFankhauser @YAUpenile_tesCa @JGomezRivas @eauyoungurology @Uroweb Congrats Fanki!!🥳🤓

I'm thrilled to collaborate with these giants on an upcoming paper. As the new chair, I'm eager to infuse @YAUpenile_tesCa with fresh research ideas. A huge thank you to @JGomezRivas, @eauyoungurology, and the entire @Uroweb team for your support

📢 Exciting update from our latest analysis, published in the @JCO_ASCO How to treat men with vital residuals in the pcRPLND specimen? MORE chemo or only follow-up? 👇 ascopubs.org/doi/abs/10.120… 🧵

Excited to share preprint of our first foray into using LLMs to augment urologic research / medicine more broadly. Amazing work by @BasilKaufmann and phenomenal mentorship by @AshTewariMD @ @MMenonMD. See what @OpenAI GPT can do for research!! 1drv.ms/b/s!AtbF5cIHC5…